Whether alpha-1 antagonists can be recommended for long-term treatment remains doubtful as the results by Roehrborn et al. (2006) demonstrate similar progression event rates for treatment with alfuzosin as for placebo [49] and results about a possible relationship between tamsulosin and the incidence of dementia remain doubtful [33, 56]. This evidence concerns the gene PSMA6 and dementia.